HEPATITIS C VIRUS NUCLEIC ACID (HCV) - ANVISA Registration 81062710040

Access comprehensive regulatory information for HEPATITIS C VIRUS NUCLEIC ACID (HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81062710040 and manufactured by CEPHEID AB. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Aug 24, 2030.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT MOLECULAR INC, ROCHE MOLECULAR SYSTEMS, INC, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.